Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.51
-$0.25 (-1.4%)
Closing Price on September 20, 2024
TEVA Articles
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better than...
Published:
Last Updated:
October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by a slim margin...
Published:
Last Updated:
The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest was mixed.
Published:
Last Updated:
October 5, 2016: Here are four stocks trading with relatively heavy volume among 25 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by nearly 2 to 1 and...
Published:
Last Updated:
October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in Monday’s session. Wells Fargo & Co. (NYSE: WFC) lost about 1.6% Monday to...
Published:
Last Updated:
September 30, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Friday’s session. Cognizant Technology Solutions Corp. (NASDAQ: CTSH)...
Published:
Last Updated:
September 29, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by 3 to 1 and Nasdaq...
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Published:
Last Updated:
We liked the list of Buy-rated stocks in a recent Jefferies research piece, as they are all good stealth plays. That is, they are top companies, under the radar, that have a big impact in their...
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva Pharmaceutical and Verifone.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include DDR, HP, L-3 Communications, Salesforce.com, Teva Pharmaceutical and Twilio.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated:
Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.
Published:
Last Updated: